Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients

Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients

  • نوع فایل : کتاب
  • زبان : انگلیسی
  • مؤلف : Nabila Chaher Hugo Arias-Pulido Nadija Terki Clifford Qualls Kamel Bouzid Claire Verschraegen Anne Marie Wallace Melanie Royce
  • چاپ و سال / کشور: 2011

Description

Inflammatory breast cancer (IBC) shows a high incidence in Tunisia and Egypt but epidemiological and molecular characteristics have not been described in Algeria. We compared 117 IBC and 59 non-IBC locally advanced breast cancers (LABC), for estrogen and progesterone receptors, HER2, and EGFR protein expression by immunohistochemistry, and HER2 gene amplification by chromogenic in situ hybridization. Demographic, clinicopathological, and molecular variables were compared with chi-square and Fisher’s exact tests to test for significance (P\0.05, two-tailed). Overall survival (OS) and diseasefree survival (DFS) were plotted using Kaplan–Meier curves and compared using the log-rank test. Tumor emboli were detected in 77% of IBC. Palpable masses were found in all LABC but only in 32% of IBC (P\0.001). Recurrences were higher in LABC than in IBC (48 vs. 35%; P = 0.14) but OS was worse in IBC (68 vs. 71%; P = 0.06). There were no significant differences between IBC and LABC by demographics or by clinico-pathological parameters. The majority of IBC and LABC tumors were luminal A (62 and 64%), followed by basal (*18%, each), triple negative (*18%, each), and HER2? (*10%, each) subtypes. In multivariate analyses, grade was associated with worse OS (P = 0.04), and DFS (P\0.001) in IBC; chemo- and radio-therapy were associated with improved OS and DFS, respectively (P\0.05 for each) in LABC. In conclusion, IBC in Algeria shows similar characteristics to IBC described for Egypt and Tunisia with subtle molecular differences. Current therapeutic treatments were not very effective in this population and new approaches are much needed.
Breast Cancer Res Treat DOI 10.1007/s10549-011-1422-5 Received: 12 January 2011 / Accepted: 21 February 2011
اگر شما نسبت به این اثر یا عنوان محق هستید، لطفا از طریق "بخش تماس با ما" با ما تماس بگیرید و برای اطلاعات بیشتر، صفحه قوانین و مقررات را مطالعه نمایید.

دیدگاه کاربران


لطفا در این قسمت فقط نظر شخصی در مورد این عنوان را وارد نمایید و در صورتیکه مشکلی با دانلود یا استفاده از این فایل دارید در صفحه کاربری تیکت ثبت کنید.

بارگزاری